Murj

Murj

Cardiology & Cardiovascular Health

About Murj

Murj is a healthcare technology company that provides comprehensive cardiac device management solutions for electrophysiology and cardiology clinics. The company offers an integrated platform that consolidates remote monitoring for cardiac implantable electronic devices (CIEDs), heart failure monitoring, ambulatory cardiac monitoring, and pulmonary artery pressure monitoring into a single intuitive application. Murj's platform addresses the challenge of vendor sprawl by connecting multiple device manufacturers and monitoring vendors through one unified interface, enabling clinics to manage their entire cardiac device patient population more efficiently. The company's solutions are designed to reduce administrative burden, improve care achievement rates, and enhance billing accuracy. Murj reports that clinics using their platform achieve up to 80 percent care achievement—more than double the national average—while realizing significant return on investment, with some clinics reporting over 700 percent ROI. Beyond software, Murj offers Clinical Services including OnTap Staffing, Backlog Reduction, Clinical Data Reconciliation, and the mPower training program developed in partnership with Arrhythmia Technologies Institute (ATI). These services provide IBHRE-certified specialists who integrate seamlessly into clinic workflows to manage transmissions, clear backlogs, and train internal staff. The company supports over 90,000 patients nationwide through its clinical services specialists. Murj's platform features EHR integration, pre-populated records, ready-to-use workflows, and Advisory Management tools that help clinics identify impacted patients quickly. The company recently expanded its global footprint to Australia and New Zealand, and evolved from its predecessor brand PaceArt to offer enhanced capabilities for modern cardiac device clinics.

Mission & Story

Mission

Our purpose is to elevate yours

Founding Story

The company evolved from PaceArt to Murj, representing an upgrade and expansion of cardiac device management capabilities

Clinical Focus

Medical conditions and clinical areas addressed by Murj.

Cardiac arrhythmiasHeart failureCardiovascular conditions requiring implantable devices

Who It Serves

Electrophysiology clinicsCardiology practicesHealth systemsAcademic medical centers

Milestones & Awards

Recent Milestones

Expanded global footprint to Australia and New Zealand in 2025-2026; evolved from PaceArt brand to Murj with enhanced platform capabilities; presented multiple research abstracts at HRS 2026 Scientific Sessions

Key Partnerships

Arrhythmia Technologies Institute (ATI)University of Kansas Health SystemUniversity of South FloridaDeborah Heart and Lung Center

Company Details

Work here?

Claim this listing to update company information and connect with our audience.

Claim This Listing

Security & Compliance

HIPAA
Last updated Jun 30, 2026

Similar Companies in this Market

View all 64
AccurKardia

AccurKardia

AI-powered platform for cardiovascular disease detection and cardiac risk assessment.

Acorai

Acorai

AI platform for cardiovascular disease detection and cardiac risk assessment.

Aisap

Aisap

11-50 employees

AISAP provides FDA-cleared AI-powered diagnostic algorithms embedded in an operating system for point-of-care ultrasound (POCUS) devices. The platform enables rapid, expert-level cardiac imaging interpretation at the bedside, helping physicians detect structural heart disease early and make faster clinical decisions across hospitals, clinics, and screening programs.

AliveCor

AliveCor

AliveCor develops FDA-cleared, AI-powered ECG devices and software platforms for cardiac monitoring. The company offers portable ECG solutions ranging from consumer personal devices to clinical-grade 12-lead systems, serving patients, healthcare providers, biopharma companies, and health systems with remote and connected cardiac care.

Anumana AI

Anumana AI

series c · 175 employees

Anumana AI develops and delivers AI-driven ECG algorithms to enable early diagnosis and intervention for cardiovascular conditions.

Artrya

Artrya

11-50 employees

Artrya develops AI-powered solutions for rapid assessment of chest pain patients in emergency and primary care settings. The company's technology analyzes coronary computed tomography angiography (CCTA) to detect arterial plaque and stratify patient risk within minutes.

Bay Labs

Bay Labs

Bay Labs is a health AI company focused on cardiology and cardiovascular health. The company's website is currently under construction with limited public information available.

BunkerHill Health

BunkerHill Health

Bunkerhill Health provides Carebricks, an AI-powered platform that enables health systems to design, deploy, and operationalize AI agents across clinical and operational workflows. The platform reasons across patient data and automates actions within existing EHR systems.

Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.